Avant-garde Health’s Post

All you need to know about the advent of #CMS-mandated PRO collection for THA and TKA including rapidly-approaching timelines, data specifications, inclusion/exclusion criteria, and implications for orthopedic providers: https://lnkd.in/ezxdrrX9 #Orthopedics #CMSDeadlines

Dr. Karl Koenig’s points in this article that Dr. Benjamin Schwartz, MD, MBA highlights really resonate with me. As value based care gradually gets implemented upstream digital health companies can play a significant role. A “digital door” to streamline appointments and guide patients to the appropriate care augmented (not replaced) by virtual care and perhaps AI enabled conversational platforms can be impactful— but musculoskeletal care providers and Orthopaedic surgeons have to be involved in the architecture of that “door”. There’s opportunity for synergy but the approach to date has been fragmented and left us out of the loop. I also think these digital platforms and AI companies have largely ignored underserved patient populations (this is true at least in MSK care— there are lots of cool companies focusing on Medicaid populations but not emphasizing Orthopaedics). You’d be surprised how many companies don’t even offer their platform in Spanish, or have a secure text message option for patients without smart phones. It will be important to see the aisle between DHCs and Orthopaedic surgeons being crossed, especially as value based care becomes more prevalent and population health becomes a cornerstone of the way we care for patients.

Like fragility fractures of the hip, Fragility fractures of the Pelvis (FFP) are very painful and can result in long periods of immobility; however, only 10% of FFP patients undergo surgery today, compared to 95% of hip fracture patients. The goal of surgery for FFP is to stabilize the broken bones to alleviate the pain, increasing the likelihood of mobilization (the ability to get up and move/walk) while fracture healing takes place, which can take up to 12 weeks. This is especially important for geriatric patients. See how CurvaFix ix can help…. #trauma #fragility #fracture

Finding the right clinic is crucial for your overall well-being when seeking orthopedic care. But Suburban Orthopaedics, located in Elgin, Bartlett, Downtown Chicago, and Elk Grove Village, always has providers to help you! 💪 To ensure you make an informed decision about your orthopedic health, check out the ten essential questions to ask when visiting a Suburban Orthopaedics clinic with the link below 👇 https://lnkd.in/gdSsBNqS #chicagoorthopedics #chicagobonespecialist #orthoexpert

The relationship between MSK-focused digital health companies (DHC) and Orthopedic Surgeons is a complicated one. To this point, it could be argued it has been more adversarial than collaborative. Both sides want the same thing: high-quality, evidence-based treatment that's cost-effective, timely, and accessible. Pretty simple, right? In reality, the situation isn't quite so straightforward. To DHCs, Orthopaedic Surgeons are viewed as purveyors of low value, unnecessary care, incentivized by the FFS to favor lucrative procedures over less costly, less invasive, and equally effective treatments. Their core value proposition has been to reduce MSK spend by keeping patients/employees away from knife-happy bone docs. To Orthopaedic Surgeons, DHCs are unwelcome gatekeepers themselves incentivized to push less costly but potentially inappropriate care that delays definitive treatment. To Orthopods, DHCs don't know what they don't know and aren't equipped for when patients' needs outstrip their capabilities. Though there is some truth in these assessments, can the sides ever find common ground? How can each side provide value to the other? Patients benefit from the multi-disciplinary, holistic approach and ease of access provided by DHCs. Orthopods benefit when lower acuity problems or appropriate conservative treatment by DHCs. On the other side, DHCs benefit by having Orthopods as a vetted resource for higher acuity, more complex problems and by establishing networks of high value specialists. As CMS, self-insured employers, and direct contractors seek out alternative models, DHCs and Orthopedic Surgeons can work together in risk-sharing models to achieve VBC MSK goals for the benefit of all. Pressure is mounting on both sides. Unicorn (or once-unicorn) MSK DHCs are being pushed by investors to find an exit. Going public will lay bare the effectiveness of both their clinical and business model. The guess here is that lack of integration with traditional, brick-and-mortar care and inability to drive ROI and growth beyond procedure avoidance will be a hinderance --full spectrum treatment a differentiator. Orthopods are facing a future driven by accountable care, mandatory participation in VBC models, and condition-specific episodes of care. Inability to adapt or provide the services needed to thrive in these models risks obsolescence. Partnering with DHCs can help Orthopedic Surgeons more effectively navigate the requirements of a more integrated approach (including health coaching, virtual PT, RPM/RTM, PROMS, etc.). Will the sides cross the aisle and embrace collaboration? Or do both still believe they can go it alone? Is the door opening or closing? #medicine #health #healthcare #healthtech #healthcaretechnology #digitalhealth #msk #healthcareinnovation

Total joint replacement surgical trays are what we specialize in at SPDx. Total joint replacements are becoming more common in the outpatient surgery center as technology advances, pain management improves and organizations build an infrastructure around recovering at home. The push for value-based care is transitioning higher acuity cases into outpatient centers when appropriate. SPDx increases asset utilization, ensures chain of custody, and enables more safe procedures in each ASC we service.

Excellent article that analyzes orthopedic patient-centric pathways and moves that could increase cooperation among payers and care teams to promote evidence-based care and therefore improve outcomes and affordability for patients. #orthopedic #healthcare

The global Outpatient Surgery Centers market was valued at US$ 304240 million in 2023 and is anticipated to reach US$ 478410 million by 2030 witnessing a CAGR of 6.6% during the forecast period 20242030. #GlobalOutpatientSurgeryCentersMarket #SingleSpecialtyCenters #MultiSpecialtyCenters #Ophthalmology #PainManagement #Gastroenterology #Orthopedics #MarketOutlook #HealthcareInvestment #MarketGrowth